References
- Kagan J. Galen's Prophesy: temperament in human nature. BasicBooks, New York 1994
- Bergerman CS, Chipuer HM, Plomin R, Pedersen NL, McClean GE, Nesselroade JR. Genetic and environmental effects on openness to experiences, agreeableness and conscientiousness: an adoption/twin study. J Pers 1993; 61: 159–79
- McCrae RR, Costa JPT, Ostendorf F, Angleitner A, Hrebickova M, Avia MD, et al. Nature over Nurture: temperament, personality and life span development. J Pers Soc Psychol 2000; 78: 173–86
- Nowakowska C, Strong CM, Santosa CM, Wang PW, Ketter TA. Temperamental commonalities and differences in euthymic mood disorder patients, creative controls, and healthy controls. J Affect Disord 2005; 85: 207–15
- Akiskal KK, Akiskal HS. The theoretical underpinnings of affective temperaments: implications for evolutionary foundations of bipolar disorder and human nature. J Affect Disord 2005; 85: 231–9
- Akiskal HS. Toward a temperament-based approach to depression: implications for neurobiologic research. Adv Biochem Psychopharmacol 1995; 49: 99–112
- Gonda X, Rihmer Z, Zsombok T, Bagdy G, Akiskal K, Akiskal HS. The 5HTTLPR polymorphism of serotonin transporter gene is associated with affective temperament as measured by TEMPS-A. J Affect Disord 2006; 91: 125–31
- Cloninger CR. A unified biosocial theory of personality and its role in the development of anxiety states: a reply to commentaries. Psychiatr Dev 1988; 6(2)83–120
- Hirschfeld R, Shea T. Personality. Handbook of affective disorders, E Paykel. Guilford Press, New York 1992; 185–94
- Clark LA, Watson D, Mineka S. Temperament, personality, and the mood and anxiety disorders. J Abnorm Psychol 1994; 103: 103–16
- Regier DA, Rae DS, Narrow WE, Kaelber CT, Schatzberg AF. Prevalence of anxiety disorders and their comorbidity with mood and addictive disorders. Br J Psychiatry 1998; 34: 24–8
- Arborelius L, Owens MJ, Plotsky PM, Nemeroff CB. The role of corticotropin-releasing factor in depression and anxiety disorders. J Endocrinol 1999; 160: 1–12
- Sheline YI. Hippocampal atrophy in major depression: A result of depression-induced neurotoxicity?. Mol Psychiatry 1996; 1: 298–9
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Press; 1994.
- Erfurth A, Gerlach AL, Hellweg I, Boenigk I, Michael N, Akiskal HS. Studies on German (Münster) version of the temperament auto-questionnaire TEMPS-A: construction and validation of the briefTEMPS-M. J Affect Disord 2005; 85: 53–69
- Derogatis LR, Lipman RS, Covi L. SCL-90: An outpatient psychiatric rating scale – preliminary report. Psychopharmacol Bull 1973; 9(1)13–28
- Watson D, O'Hara MW, Stuart S. Hierarchical structures of affect and psychopathology and their implications for the classification of emotional disorders. Depress Anxiety 2008; 25(4)282–8
- Maser J, Cloninger R. Comorbidity of anxiety and mood disorder: Introduction and overview. Comorbidity of anxiety and mood disorder, J Maser, R Coninger. American Psychiatric Press, Washington, DC 1990; 3–13
- Brown TA, Campbell LA, Lehman CL, Grisham JR, Mancill RB. Current and lifetime comorbidity of DSM-IV anxiety and mood disorders in a large clinical sample. J Abnorm Psychol 2001; 110(4)585–99
- Tyrer P. The case for cothymia: mixed anxiety and depression as a single diagnosis. Br J Psychiatry 2001; 179: 191–3
- Maremmani I, Pardini L, Balestri C, Perugi G. Dimensioni temperamentali nei disturbi dell'umore e d'ansia: valutazione di 186 pazienti ambulatoriali. G Ital Psicopatol 1997; 3(3)11–15
- Savino M, Perugi G, Simonini E, Soriani A, Cassano GB, Akiskal HS. Affective comorbidity in panic disorder: is there a bipolar connection?. J Affect Disord 1993; 28(3)155–63
- Akiskal HS, Mendlowicz MV, Jean-Luis G, Rapaport MH, Kelsoe JR, Gillin JC, et al. TEMPS-A: validation of a short version of a self-rated instrument designed to measure variations in temperament. J Affect Disord 2005; 85: 45–52
- Corcoran C, McAllister-Williams RH. Maximizing treatment outcomes in the depressed patient. Br J Hosp Med 2007; 68(7)373–5
- Koponen H, Allgulander C, Erickson J, Dunayevich E, Pritchett Y, Detke MJ, et al. Efficacy of duloxetine for the treatment of generalized anxiety disorder: Implications for primary care physicians. Primary Care Companion J Clin Psychiatry 2007; 9(2)100–7